Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 57.8 NOK 0.17%
Market Cap: 1.6B NOK
PHO
/
Income Statement
/
Operating Income

Photocure ASA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Photocure ASA
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Photocure ASA
OSE:PHO
Operating Income
kr20.4m
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
V
Vistin Pharma ASA
OSE:VISTN
Operating Income
kr85.3m
CAGR 3-Years
37%
CAGR 5-Years
38%
CAGR 10-Years
N/A
N
Navamedic ASA
OSE:NAVA
Operating Income
kr31.8m
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
18%
S
SoftOx Solutions AS
OSE:SOFTX
Operating Income
-kr64.2m
CAGR 3-Years
10%
CAGR 5-Years
-25%
CAGR 10-Years
N/A

Photocure ASA
Glance View

Market Cap
1.6B NOK
Industry
Pharmaceuticals

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

PHO Intrinsic Value
72.89 NOK
Undervaluation 21%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Photocure ASA's Operating Income?
Operating Income
20.4m NOK

Based on the financial report for Dec 31, 2024, Photocure ASA's Operating Income amounts to 20.4m NOK.

What is Photocure ASA's Operating Income growth rate?
Operating Income CAGR 5Y
-14%

Over the last year, the Operating Income growth was -27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.